title: Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?
authors.affiliation: Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, Valencia, España. Electronic address: blancaunamuno@yahoo.es.
authors.forename: B
authors.initials: B
authors.lastname: de Unamuno-Bustos
authors.affiliation: Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Ballester-Sánchez
authors.affiliation: Servicio de Anatomía Patológica, Consorcio Hospital General Universitario de Valencia, Valencia, España.
authors.forename: V
authors.initials: V
authors.lastname: Sabater Marco
authors.affiliation: Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, Valencia, España.
authors.forename: J J
authors.initials: JJ
authors.lastname: Vilata-Corell
mesh_terms: D000368:Aged; D003882:Dermatomyositis / Q000175:diagnosis*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D057915:Drug Substitution; D004890:Erythema / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D007871:Leg Ulcer / Q000139:chemically induced / Q000473:pathology; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use
chemical_list: D011799:Quinazolines; C021139:anagrelide; D006918:Hydroxyurea